Table 1.
Composition of MLVs containing DOPE-TLR7a conjugate, TDB and DOPE.
| MLV composition | TDB w%/v% (μM) | DOPE-TLR7a agonist w%/v% (μM) | DOPE w%/v% (μM) |
|---|---|---|---|
| 0% DOPE-TLR7a − TDB | 0 (0) | 0 (0) | 20 (336) |
| 0% DOPE-TLR7a + TDB | 20 (250) | 0 (0) | 20 (336) |
| 1% DOPE-TLR7a − TDB | 0 (0) | 1 (11.5) | 19 (320) |
| 20% DOPE-TLR7a − TDB | 0 (0) | 20 (230) | 0 (0) |
| 20% DOPE-TLR7a + TDB | 20 (250) | 20 (230) | 0 (0) |